ACE inhibitor use and the long-term risk of renal failure in diabetes [12]

Kidney International

Volumn 70, Issue 7, 2006, Pages 1376-1377

  Woo, K T ^a   Lau, Y K ^a   Wong, K S ^a   Chan, C M ^a  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; TRANSFORMING GROWTH FACTOR BETA;

CELL PROLIFERATION; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DISEASE COURSE; DRUG EFFICACY; GLOMERULOSCLEROSIS; GLOMERULUS; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; INCIDENCE; KIDNEY FAILURE; LETTER; MESANGIUM CELL; PRIORITY JOURNAL; PROTEINURIA; RENAL PROTECTION; RISK ASSESSMENT;

ANGIOTENSIN II; ANGIOTENSIN RECEPTOR ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CHI-SQUARE DISTRIBUTION; DIABETES MELLITUS; DIABETIC NEPHROPATHIES; DISEASE PROGRESSION; FOLLOW-UP STUDIES; HUMANS; KIDNEY FAILURE, CHRONIC; PROTEINURIA; RANDOMIZED CONTROLLED TRIALS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECEPTORS, ANGIOTENSIN; RISK FACTORS; TIME FACTORS; TRETINOIN;

EID: 33748946573     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/sj.ki.5001733     Document Type: Letter

References (3)

1. Suissa S, Hutchison T, Brophy JM, Kezouh A. ACE-inhibitor use and long term risk of renal failure in diabetes. Kidney Int 2006; 69: 913-919.
2. Woo KT, Lau YK, Wong KS, Chiang GS. ACEI/ATRA therapy decreases proteinuria by improving glomerular permselectivity in IgA nephritis. Kidney Int 2000; 58: 2485-2491.
3. Nakamura T, Obata J, Kimura H et al. Blocking angiotensin II ameliorates proteinuria and glomerular lesions in progressive mesangioproliferative glomerulonephritis. Kidney Int 1999; 55: 877-889.